Proof in the Patient: What CR Outcomes Reveal About T and NK Cell Platform
18 Sep 2025
Allogeneic Access: Engineering the Future of Cell Therapy
- Key differences in process design, scalability, and consistency between T cell and NK cell platforms.
- How complete response (CR) outcomes confirm the reliability and effectiveness of manufacturing strategies.
- Exploring correlative and response data to compare NK cell cytotoxicity with T cell therapeutic performance.
